Compass Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol: CMPX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 80 Guest Street, Boston, MA

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+40K	0.6%	$1.48	+$59.2K
Sells	2	-7.14M	99.4%	$1.59	-$11.4M
Net	0	-7.1M	-98.9%		-$11.3M

Compass Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Thomas J. Schuetz	CHIEF EXECUTIVE OFFICER, Director	$22.6M			Feb 11, 2025
Vered Bisker-Leib	CHIEF EXECUTIVE OFFICER, Director	$4.53M			Feb 8, 2024
Barry Shin	Cfo	$660K			Feb 11, 2025
Neil Lerner	Chief Accounting Officer	$454K	+$28.4K	+6.67%	Apr 7, 2025
Jonathan Anderman	Gen Counsel & Corporate Sec	$32.3K	+$30.8K	+2000%	Apr 7, 2025
Orbimed Advisors Llc	Director, 10%+ Owner	$0	-$5.68M	-100%	Apr 9, 2025
Carl L. Gordon	Director, 10%+ Owner	$0	-$5.68M	-100%	Apr 9, 2025
Susan Kalled	Chief Scientific Officer				Feb 18, 2022
Richard S. Lindahl	Director				Feb 11, 2025
Mary Ann Gray	Director				Feb 11, 2025
Brett Kaplan	Director				Feb 18, 2022
David M. Wurzer	Director				Feb 8, 2023
Stephen P. Squinto	Director				Feb 18, 2022
Ellen Chiniara	Director				Feb 11, 2025
James P. Boylan	Director				Feb 11, 2025
Miranda Jayne Toledano	Director				Jun 25, 2021
Philip Ferneau	Director				Feb 11, 2025

Recent Insider Transactions by Companies or Individuals for Compass Therapeutics, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.